Novo Nordisk posts strong nine-month results
October 29, 2015Sales and Marketing Novo Nordisk, insulin
Novo Nordisk has exceeded market expectations in its nine-month financial results, reporting a 51% increase in operating profit and 33% …
Bayer posts strong earnings growth
October 29, 2015Manufacturing and Production, Research and Development, Sales and Marketing
Sales across the Bayer group rose by 1.9% in the third quarter of 2015 to €11 billion, according the company’s …
Novartis launches new hypertension program in Ghana
October 29, 2015Research and Development
The Novartis Foundation and its partners have begun screening patients in a Community-based Hypertension Improvement Project (ComHIP) in Ghana in …
Pfizer in ‘friendly’ merger talks with Allergan
October 29, 2015Sales and Marketing Actavis, Allergan, Pfizer, Teva
Pfizer is in talks with Allergan over what could be the largest takeover deal in an already record-breaking year, it …
Baxter names José Almeida chairman and chief executive
October 29, 2015Manufacturing and Production, Research and Development, Sales and Marketing Joe Almeida, José Almeida, baxter
Baxter has named José (Joe) Almeida as the company’s new chairman and chief executive from January 1, 2016. Almeida will …
Dr Jane Osbourn to join BIA board as chair
October 28, 2015Dr Jane Osbourn, the vice president of research and development at MedImmune, will be the new chair of the BIA …
FDA approves first-in-class Amgen melanoma drug
October 28, 2015Research and Development, Sales and Marketing Amgen, Imlygic, melonoma
The US Food and Drug Administration (FDA) has approved Amgen’s Imlygic for the treatment of melanoma lesions in the skin …
Otsuka kidney drug earns first NICE nod
October 28, 2015Research and Development, Sales and Marketing NHS, NICE, jinarc, kidney disease, tolvaptan
NICE has released final guidance recommending Otsuka’s Jinarc, the first-ever treatment shown to slow progression of life-threatening Autosomal Dominant Polycystic …
Sales up at MSD while Keytruda hits survival target in late-stage trial
October 28, 2015Research and Development, Sales and Marketing MSD, Merck, financial results, keytruda, pembrolizumab
Worldwide sales at MSD were $10.1 billion in the third quarter of 2015, a 4% increase after accounting for the …
Otsuka, GW announce Sativex fails in Phase III cancer pain trials
October 28, 2015Research and Development, Sales and Marketing Cancer, GX Pharmaceuticals, Otsuka, Sativex, cancer pain, palliative care, phase III, phase III failure
Otsuka and GW Pharmaceuticals cannabis-based drug Sativex failed to show superiority over placebo in two Phase III trials.The studies were …
OPINION: ‘More work remains if biosimilars are to fulfil their potential’
October 27, 2015Manufacturing and Production, Research and Development, Sales and Marketing British Generic Manufacturers Association, NHS, bgma, biosimilars, generics, patent cliff, patents
Despite having a mature generics market which fulfils more than three-quarters of all prescriptions in the UK, and as a …
Pharma reaction to the Government’s AAR review
October 27, 2015Manufacturing and Production, Research and Development Accelerated Access Review
The long-awaited interim report on the Government’s Accelerated Access Review has been published.The Government department overseeing the report, the Office …
New Phase III data puts Shire’s lifitegrast back on track for 2016 launch
October 27, 2015Research and Development Shire, dry eye disease, lifitegrast
Shire shares rose 6% today as the company reported new positive Phase III trial data for lifitegrast in the treatment …
EMA launches scheme to prioritise medicines access for patients
October 27, 2015Manufacturing and Production EMA, European Medicines Agency, medicines access
The EMA has launched a public consultation on a scheme which aims to enable access to more medicines.The PRIME scheme …
North of England secures new ‘centres of excellence’ in ‘precision medicine’
October 27, 2015Manufacturing and Production, Research and Development NHS, Northern Health Science Alliance, UK
The umbrella group formed by the leading northern universities, teaching hospitals and Academic Health Science Networks – the Northern Health …
Roche under pressure to drop price of Kadcyla
October 27, 2015Manufacturing and Production Cancer Drugs Fund, Kadcyla, Roche, breast cancer
The UK’s largest breast cancer charity has called for drug manufacturer Roche to drop the price of Kadcyla before it …
Revealed: recommendations from the Accelerated Access Review
October 27, 2015Manufacturing and Production, Research and Development Accelarated Access Review, NHS
Ministers have been urged to introduce conditional approvals for innovative new drugs, and ‘radically new’ central agreements on drug pricing, …
Novartis misses Q3 forecast with $390m settlement payment, strong dollar
October 27, 2015Manufacturing and Production, Sales and Marketing Alcon, Novartis, Sandoz
Novartis reported lower-than anticipated third quarter earnings on Tuesday, hit by the $390 million settlement it has agreed to pay …
Valeant CEO rejects fraud accusations in conference call
October 27, 2015Manufacturing and Production, Medical Communications, Sales and Marketing
Valeant says it will establish a committee to review allegations about the company’s relationship with specialist pharmacy Philidor, following what …
GSK’s Volibris gets pulmonary arterial hypertension approval in Europe
October 26, 2015Research and Development, Sales and Marketing EMA, GSK
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
